13553-79-2: Rifaximin EP Impurity E
It is an impurity of Rifaximin. Rifaximin is employed to treat the symptoms of Traveler’s Diarrhea caused by Escherichia coli, Hepatic Encephalopathy, and Irritable Bowel Syndrome with diarrhea.
Additional information on CAS 13553-79-2
Catalogue No.
VL4360004
CAS No.
13553-79-2
Molecular Formula
C37H45NO12
Molecular Weight
695.76
Parent drug
Rifaximin
IUPAC Name
5, 17, 19, 21-Tetrahydroxy-23-methoxy-2, 4, 12, 16, 18, 20, 22-heptamethyl-2, 7-(epoxypentadeca[1, 11, 13]trienimino)naphtho[2, 1-b]furan-1, 6, 9, 11(2H)-tetrone 21-Acetate
Synonyms
Rifaximin BP Impurity E / Rifamycin S / Rifamycin EP Impurity B
References
“Sci-Hub, Rifaximin Treatment in Hepatic Encephalopathy, 10.1056/NEJMoa0907893.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1056/NEJMoa0907893.
Status
In-stock
